AI-powered drug discovery: is it the next frontier of medicine? From cutting down costs, to speeding up development, the technology promises plenty - but can it deliver? In this episode, Bloomberg's Tom Mackenzie speaks exclusively to Demis Hassabis, the Nobel Laureate aiming to literally "solve all disease" through his work at London-based Isomorphic Labs. Hassabis' work comes in addition to his responsibilities at Alphabet Inc., where he oversees all of the company's core AI work as co-founder and CEO of Google DeepMind. --- "Bloomberg Tech: Europe" spotlights the biggest names and trends shaping the region's technology ecosystem as the global competition heats up. This monthly, 30-minute magazine-style show features in-depth interviews with top technology leaders, as well as major investors and policymakers - giving you a compelling A to Z of the most consequential innovations, opportunities and challenges.